Dermata Therapeutics (DRMAW) Short Interest Ratio & Short Volume $0.0088 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends Dermata Therapeutics Short Interest DataDermata Therapeutics (DRMAW) has a short interest of 11,400 shares. This marks a -8.06% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.9, indicating that it would take 2.9 days of the average trading volume of 10,863 shares to cover all short positions.Current Short Interest11,400 sharesPrevious Short Interest12,400 sharesChange Vs. Previous Month-8.06%Dollar Volume Sold Short$79.80Short Interest Ratio2.9 Days to CoverLast Record DateJune 15, 2024Today's Trading Volume0 sharesAverage Trading Volume10,863 sharesToday's Volume Vs. Average0% Short Selling Dermata Therapeutics? Sign up to receive the latest short interest report for Dermata Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDRMAW Short Interest Over TimeDRMAW Days to Cover Over TimeDRMAW Percentage of Float Shorted Over Time Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Dermata Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202411,400 shares $79.80 -8.1%N/A2.9 $0.01 5/31/202412,400 shares $100.44 +11.7%N/A2.9 $0.01 5/15/202411,100 shares $187.59 -2.6%N/A2.2 $0.02 4/30/202411,400 shares $108.30 +3.6%N/A2.5 $0.01 4/15/202411,000 shares $101.20 +15.8%N/A2.2 $0.01 3/31/20249,500 shares $90.25 -24.6%N/A1.6 $0.01 Get the Latest News and Ratings for DRMAW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/15/202412,600 shares $141.12 +20.0%N/A2.2 $0.01 2/29/202410,500 shares $165.90 -8.7%N/A1.8 $0.02 2/15/202411,500 shares $143.75 +17.4%N/A2.3 $0.01 1/31/20249,800 shares $245.00 -26.3%N/A2 $0.03 1/15/202413,300 shares $275.31 +4.7%N/A3.2 $0.02 12/31/202312,700 shares $88.90 -0.8%N/A3.3 $0.01 12/15/202312,800 shares $281.60 No ChangeN/A4.6 $0.02 11/30/202312,800 shares $268.80 No ChangeN/A5.8 $0.02 11/15/202312,800 shares $157.44 No ChangeN/A3.9 $0.01 10/31/202312,800 shares $153.60 -2.3%N/A4 $0.01 10/15/202313,100 shares $327.50 No ChangeN/A3.9 $0.03 9/30/202313,100 shares $229.25 +1.6%N/A3.4 $0.02 9/15/202312,900 shares $313.47 -18.4%N/A2.3 $0.02 8/31/202315,800 shares $284.40 +16.2%N/A2.8 $0.02 8/15/202313,600 shares $390.32 -19.5%N/A2.3 $0.03 7/31/202316,900 shares $338.00 -18.0%N/A1.7 $0.02 7/15/202320,600 shares $587.10 +57.3%N/A1.6 $0.03 6/30/202313,100 shares $327.50 -5.8%N/A0.6 $0.03 6/15/202313,900 shares $223.79 +2.2%N/A0.6 $0.02 5/31/202313,600 shares $448.80 -26.1%N/A0.6 $0.03 5/15/202318,400 shares $276.00 No ChangeN/A0.8 $0.02 8/15/2022300 shares $44.04 -57.1%N/A0 $0.15 7/31/2022700 shares $58.80 -61.1%N/A0.1 $0.08 7/15/20221,800 shares $155.34 No ChangeN/A0.2 $0.09 4/30/2022500 shares $73.50 +25.0%N/A0 $0.15 4/15/2022400 shares $63.96 -55.6%N/A0 $0.16 3/31/2022900 shares $0.00 No ChangeN/A0.1 $0.00 DRMAW Short Interest - Frequently Asked Questions What is Dermata Therapeutics' current short interest? Short interest is the volume of Dermata Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 11,400 shares of DRMAW short. Learn More on Dermata Therapeutics' current short interest. What is a good short interest ratio for Dermata Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DRMAW shares currently have a short interest ratio of 3.0. Learn More on Dermata Therapeutics's short interest ratio. Is Dermata Therapeutics' short interest increasing or decreasing? Dermata Therapeutics saw a drop in short interest in June. As of June 15th, there was short interest totaling 11,400 shares, a drop of 8.1% from the previous total of 12,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Dermata Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Dermata Therapeutics: Alvotech (0.07%), LAVA Therapeutics (0.13%), Mainz Biomed (8.71%), Pharvaris (0.76%), Procaps Group S.A. (0.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($5.04 billion), T-Mobile US, Inc. ($4.49 billion), Charter Communications, Inc. ($3.25 billion), Moderna, Inc. ($3.02 billion), General Motors ($2.91 billion), Royal Caribbean Cruises Ltd. ($2.37 billion), Cencora, Inc. ($2.19 billion), Tractor Supply ($1.82 billion), Williams-Sonoma, Inc. ($1.72 billion), and Enphase Energy, Inc. ($1.61 billion). View all of the most shorted stocks. What does it mean to sell short Dermata Therapeutics stock? Short selling DRMAW is an investing strategy that aims to generate trading profit from Dermata Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dermata Therapeutics? A short squeeze for Dermata Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DRMAW, which in turn drives the price of the stock up even further. How often is Dermata Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DRMAW, twice per month. The most recent reporting period available is June, 15 2024. More Short Interest Resources from MarketBeat Related Companies ATNFW Short Interest ALVOW Short Interest ALVO Short Interest ACABW Short Interest BFRIW Short Interest BCTXW Short Interest CELUW Short Interest CLNNW Short Interest CYTHW Short Interest ENGNW Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DRMAW) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dermata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dermata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.